Login:
 
Rees J. Is combination therapy effective for overactive bladder? Practitioner 2014; 258 (1772): 9-14

Is combination therapy effective for overactive bladder?

23 Jun 2014Pais-up subscribers

Combining an antimuscarinic with a beta-3 adrenoceptor agonist could improve the symptoms of overactive bladder (OAB), while allowing a lower dose of antimuscarinic and thus reducing side effects, results of an early study suggest. A total of 1,306 patients, at 141 centres across 20 European countries, were randomised in this study. Two-thirds of the patients were women, and all had had symptoms of OAB for 3 months or longer.  [With external links to the current evidence base]

Paid-up subscribersThis article can be accessed only if you are a paid-up subscriber to The Practitioner.

To view current online and print subscription rates, and to contact the subscription department, click Subscribe today .

To buy this article (£25+tax) copy the article citation above and click Buy article